- Home
- NABL vs NVCR Comparison
NABL vs NVCR Comparison
Compare NABL & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NABL
- NVCR
- Stock Information
- Founded
- NABL 2000
- NVCR 2000
- Country
- NABL United States
- NVCR Switzerland
- Employees
- NABL N/A
- NVCR N/A
- Industry
- NABL Computer Software: Prepackaged Software
- NVCR Medical/Dental Instruments
- Sector
- NABL Technology
- NVCR Health Care
- Exchange
- NABL Nasdaq
- NVCR Nasdaq
- Market Cap
- NABL 1.5B
- NVCR 1.4B
- IPO Year
- NABL N/A
- NVCR 2015
- Fundamental
- Price
- NABL $7.57
- NVCR $14.04
- Analyst Decision
- NABL Buy
- NVCR Buy
- Analyst Count
- NABL 4
- NVCR 7
- Target Price
- NABL $9.31
- NVCR $28.79
- AVG Volume (30 Days)
- NABL 734.8K
- NVCR 1.9M
- Earning Date
- NABL 11-06-2025
- NVCR 10-30-2025
- Dividend Yield
- NABL N/A
- NVCR N/A
- EPS Growth
- NABL N/A
- NVCR N/A
- EPS
- NABL 0.01
- NVCR N/A
- Revenue
- NABL $482,397,000.00
- NVCR $630,160,000.00
- Revenue This Year
- NABL $9.79
- NVCR $6.68
- Revenue Next Year
- NABL $8.97
- NVCR $7.01
- P/E Ratio
- NABL $494.70
- NVCR N/A
- Revenue Growth
- NABL 7.40
- NVCR 14.58
- 52 Week Low
- NABL $6.07
- NVCR $10.87
- 52 Week High
- NABL $13.04
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- NABL 35.95
- NVCR 60.46
- Support Level
- NABL $7.70
- NVCR $12.61
- Resistance Level
- NABL $8.03
- NVCR $14.77
- Average True Range (ATR)
- NABL 0.22
- NVCR 0.55
- MACD
- NABL -0.06
- NVCR 0.19
- Stochastic Oscillator
- NABL 9.19
- NVCR 67.68
About NABL N-able Inc.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.